Annexon (ANNX) Capital Expenditures (2019 - 2026)

Annexon's (ANNX) quarterly Capital Expenditures came in at -$275000.0 in Q1 2026, down 471.62% year-on-year from $74000.0 in Q1 2025, and down 105.32% quarter-over-quarter from $5.2 million in Q4 2025.

Annexon (ANNX) Capital Expenditures (2019 - 2026) Analysis & Trends

Annexon's Capital Expenditures history runs 8 years deep, the most recent figure standing at -$275000.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 471.62% year-over-year to -$275000.0 in Q1 2026; TTM through Mar 2026 was $5.0 million, a 1007.59% increase from a year earlier, with the FY2025 full-year figure at $5.3 million, up 35306.67% from the prior year.
  • Capital Expenditures retreated to -$275000.0 in Q1 2026 per ANNX's latest filing, from $5.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $5.2 million in Q1 2022 and bottomed at -$5.1 million in Q2 2022.
  • The 5-year median for Capital Expenditures is $19000.0 (2023), against an average of $380400.0.
  • Across the five-year window, Capital Expenditures surged 86133.33% in 2025 and tumbled 471.62% in 2026, its largest moves.
  • Year by year, Capital Expenditures stood at -$8000.0 in 2022, then surged by 187.5% to $7000.0 in 2023, then slipped by 14.29% to $6000.0 in 2024, then jumped by 86133.33% to $5.2 million in 2025, then slumped by 105.32% to -$275000.0 in 2026.
  • Per Business Quant, the three latest ANNX Capital Expenditures figures stand at -$275000.0 (Q1 2026), $5.2 million (Q4 2025), and $48000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -8,939.03
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 43.25 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 786,000.00
10 Annexon 1.02 Bn 798.41 Mn - -275,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -275,000.00
Mar 31, 2026 -275,000.00
Dec 31, 2025 5.17 Mn
Dec 31, 2025 5.17 Mn
Sep 30, 2025 48,000.00
Sep 30, 2025 48,000.00
Jun 30, 2025 15,000.00
Jun 30, 2025 15,000.00
Mar 31, 2025 74,000.00
Mar 31, 2025 74,000.00
Dec 31, 2024 6,000.00
Dec 31, 2024 6,000.00
Mar 31, 2024 361,000.00
Mar 31, 2024 361,000.00
Dec 31, 2023 7,000.00
Dec 31, 2023 7,000.00
Sep 30, 2023 19,000.00
Sep 30, 2023 19,000.00
Jun 30, 2023 162,000.00
Jun 30, 2023 162,000.00